Yasushi Hara Selected Research

Dopamine Agonists (Dopamine Agonist)

8/2018

Protein expression of somatostatin receptor 2, somatostatin receptor 5 and dopamine D2 receptor in normal pituitary gland and ACTH-secreting pituitary adenoma in dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Hara Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 09/2002
6	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2020
5	Adrenocortical Hyperfunction (Adrenal Gland Hyperfunction) 01/2022 - 07/2003
5	ACTH-Secreting Pituitary Adenoma 01/2020 - 08/2006
5	Pituitary ACTH Hypersecretion 04/2010 - 01/2009
4	Rupture 02/2024 - 06/2006
4	Intervertebral Disc Displacement (Herniated Disc) 10/2023 - 03/2005
4	Osteoarthritis 09/2020 - 01/2013
4	Inflammation (Inflammations) 07/2019 - 06/2006
4	Intervertebral Disc Degeneration 01/2015 - 01/2008
3	Pathologic Constriction (Stenosis) 01/2023 - 04/2020
3	Adenoma (Adenomas) 11/2022 - 07/2003
3	Wounds and Injuries (Trauma) 07/2012 - 01/2002
2	Cushing Syndrome 01/2023 - 04/2010
2	Pituitary Neoplasms (Pituitary Adenoma) 11/2022 - 01/2020
2	Carcinogenesis 01/2020 - 06/2011
2	Sepsis (Septicemia) 07/2019 - 07/2005
2	Infections 07/2019 - 01/2018
2	Spinal Cord Injuries (Spinal Cord Injury) 08/2016 - 02/2015
2	Hypertrophy 10/2015 - 08/2006
2	Ischemia 04/2008 - 12/2002
2	Diabetes Insipidus 01/2006 - 01/2003
2	Hip Dislocation 12/2005 - 10/2002
1	Osteosarcoma (Osteogenic Sarcoma) 04/2024
1	Chondrosarcoma 01/2023
1	Congenital Abnormalities (Deformity) 01/2023
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2023
1	Pituitary Apoplexy 11/2022
1	Triple Negative Breast Neoplasms 12/2021
1	Joint Instability (Joint Laxity) 09/2020
1	Hyperplasia 01/2020
1	B-Cell Leukemia (Leukemia, B Cell) 01/2019
1	Ganglioglioma 01/2019
1	Leukemia 01/2019
1	Melanoma (Melanoma, Malignant) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017

Drug/Important Bio-Agent (IBA)

7	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2022 - 07/2003
4	Aldehyde Dehydrogenase 1 FamilyIBA 01/2024 - 12/2021
4	Small Interfering RNA (siRNA)IBA 11/2022 - 01/2020
4	CytokinesIBA 01/2013 - 12/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 12/2002
4	Interleukin-6 (Interleukin 6)IBA 04/2008 - 12/2002
3	Phenobarbital (Luminal)FDA Link 01/2024 - 07/2022
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2018
3	Hormones (Hormone)IBA 08/2018 - 07/2003
3	Proteoglycans (Proteoglycan)IBA 10/2015 - 03/2005
3	Matrix Metalloproteinases (MMPs)IBA 06/2006 - 03/2005
2	NitrogenIBA 04/2024 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2019
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2009
2	3- (1,3- benzothiazol- 2- yl)- 4- (4- methoxyphenyl)but- 3- enoic acidIBA 12/2021 - 11/2018
2	Trypan Blue FDA Link 12/2021 - 01/2020
2	Propofol (Diprivan)FDA LinkGeneric 07/2013 - 05/2003
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2010 - 01/2009
2	Messenger RNA (mRNA)IBA 01/2009 - 07/2005
2	InterleukinsIBA 04/2008 - 12/2005
2	A73025IBA 06/2006 - 12/2005
2	Interleukin-1beta (Interleukin 1 beta)IBA 06/2006 - 12/2002
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	Polymethyl Methacrylate (Sol)IBA 01/2022
1	Corticotropin-Releasing HormoneIBA 01/2022
1	Atrial Natriuretic Factor (ANF)IBA 12/2021
1	Protein Kinase CIBA 12/2021
1	ClaudinsIBA 01/2021
1	Auranofin (Ridaura)FDA Link 01/2020
1	GSK 1363089IBA 01/2020
1	CaspasesIBA 01/2020
1	C-Reactive ProteinIBA 07/2019
1	TransposasesIBA 01/2019
1	Histones (Histone)IBA 01/2019
1	ChromatinIBA 01/2019
1	LipidsIBA 01/2019
1	Melanocyte-Stimulating Hormones (MSH)IBA 08/2018
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 08/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 08/2018
1	Dopamine Agonists (Dopamine Agonist)IBA 08/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2018
1	somatostatin receptor 5IBA 08/2018
1	somatostatin receptor 2IBA 08/2018
1	LigandsIBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2016
1	Neuroprotective AgentsIBA 08/2016

Therapy/Procedure

7	Hypophysectomy 01/2019 - 01/2003
5	Therapeutics 01/2013 - 07/2003
4	Osteotomy 02/2024 - 10/2002
3	Surgical Decompression 11/2022 - 02/2015
3	Anesthesia 07/2013 - 01/2002
2	Surgical Amputation (Amputations) 04/2024 - 01/2023
2	Radiotherapy 01/2024 - 09/2002
2	Laminectomy 01/2022 - 04/2020
2	General Anesthesia 01/2020 - 07/2013
1	Decompression 10/2023
1	Arthrodesis 01/2023
1	Bone Transplantation (Bone Grafting) 01/2023
1	Catheters 01/2022
1	Pedicle Screws 01/2022